We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

136 hedge funds and large institutions have $511M invested in Aldeyra Therapeutics in 2021 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 44 increasing their positions, 28 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 21

59% more call options, than puts

Call options by funds: $6.71M | Put options by funds: $4.21M

57% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 28

36% more capital invested

Capital invested by funds: $377M → $511M (+$134M)

26% more funds holding

Funds holding: 108 → 136 (+28)

11.46% more ownership

Funds ownership: 67.13% → 78.59% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
136
Holders Change
+28
Holders Change %
+25.93%
% of All Funds
2.37%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
49
Increased
44
Reduced
28
Closed
21
Calls
$6.71M
Puts
$4.21M
Net Calls
+$2.5M
Net Calls Change
+$3.29M

Top Buyers

1
BlackRock
BlackRock
New York
+$26.7M
2
PA
Perceptive Advisors
New York
+$14.4M
3
EAM
Eagle Asset Management
Florida
+$13.1M
4
WP
Woodline Partners
California
+$11.8M
5
Goldman Sachs
Goldman Sachs
New York
+$11.2M

Top Sellers

1
APM
Avidity Partners Management
Texas
-$13.3M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.76M
3
ECM
ExodusPoint Capital Management
New York
-$1.86M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.85M
5
Millennium Management
Millennium Management
New York
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$320K +$340K +28,251 New
Citadel Advisors
77
Citadel Advisors
Florida
$318K -$2.76M -229,315 -89%
IAIM
78
International Assets Investment Management
Florida
$309K -$121K -10,080 -27%
SKK
79
Shepherd Kaplan Krochuk
Massachusetts
$283K – – –
IIM
80
Ironwood Investment Management
Massachusetts
$277K – – –
GCP
81
GSA Capital Partners
United Kingdom
$259K +$275K +22,869 New
AQR Capital Management
82
AQR Capital Management
Connecticut
$256K +$272K +22,629 New
Simplex Trading
83
Simplex Trading
Illinois
$237K +$88.5K +7,359 +54%
HP
84
Hikari Power
Japan
$227K – – –
VOYA Investment Management
85
VOYA Investment Management
Georgia
$216K +$230K +19,097 New
MIM
86
MetLife Investment Management
New Jersey
$216K +$229K +19,044 New
JP Morgan Chase
87
JP Morgan Chase
New York
$211K +$224K +18,622 +38,796%
Squarepoint
88
Squarepoint
New York
$207K +$220K +18,269 New
VEA
89
Virtus ETF Advisers
New York
$206K +$219K +18,201 New
Invesco
90
Invesco
Georgia
$199K +$211K +17,551 New
Russell Investments Group
91
Russell Investments Group
United Kingdom
$179K +$191K +15,881 New
D.E. Shaw & Co
92
D.E. Shaw & Co
New York
$172K -$35.2K -2,929 -16%
AllianceBernstein
93
AllianceBernstein
Tennessee
$172K +$183K +15,200 New
UBS Group
94
UBS Group
Switzerland
$168K -$409K -34,031 -70%
MLICM
95
Metropolitan Life Insurance Company (MetLife)
New York
$165K +$175K +14,580 New
CA
96
Cetera Advisors
Colorado
$160K +$170K +14,100 New
LPL Financial
97
LPL Financial
California
$159K -$193K -16,049 -53%
Jane Street
98
Jane Street
New York
$150K -$74.6K -6,203 -32%
VF
99
Virtu Financial
New York
$145K +$154K +12,824 New
KAS
100
Kestra Advisory Services
Texas
$143K +$2.77K +230 +2%
2 3
4
5 6

ALDX Hedge Fund Activity: Q2 2021 in Review

136 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q2 2021, worth a combined $511M — up 36% from $377M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new ALDX positions and 21 closed out — a net gain of 28 holders — while 44 added to existing stakes and 28 trimmed.

The largest buyer was BlackRock, adding an estimated $26.7M. The largest seller was Avidity Partners Management, cutting an estimated $13.3M.

  • 136 institutional investors held Aldeyra Therapeutics (ALDX) as of Q2 2021, up from 108 in Q1 2021.
  • Funds reported $511M of Aldeyra Therapeutics stock for Q2 2021, up 36% quarter-over-quarter.
  • 49 funds opened new Aldeyra Therapeutics positions in Q2 2021 and 21 closed out, a net change of +28 holders.
  • The largest Aldeyra Therapeutics buyer in Q2 2021 was BlackRock, an estimated $26.7M added.
  • The largest Aldeyra Therapeutics seller in Q2 2021 was Avidity Partners Management, an estimated $13.3M sold.

Based on aggregated 13F filings for Q2 2021.